13413 results
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Accord
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,
, Revision: 16, Authorised, Last updated: 21/06/2023
Levetiracetam Accord Nervous System Diseases Central … assessment report (EPAR) for Levetiracetam Accord. It explains how the Committee … the conditions of use for Levetiracetam Accord. Expand section Collapse section … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Teva
levetiracetam, Epilepsy
Date of authorisation: 25/08/2011,, Revision: 20, Authorised, Last updated: 21/06/2023
Levetiracetam Teva Nervous System Diseases Central … Authorised levetiracetam Overview Levetiracetam Teva is an epilepsy medicine … reaches the whole brain. Levetiracetam Teva can also be used as … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Sun (updated)
levetiracetam, Epilepsy
Date of authorisation: 14/12/2011,, Revision: 19, Authorised, Last updated: 22/09/2023
Levetiracetam Sun Nervous System Diseases Central … Authorised levetiracetam Overview This is a summary … assessment report (EPAR) for Levetiracetam Sun. It explains how the … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Hospira
levetiracetam, Epilepsy
Date of authorisation: 07/01/2014,, Revision: 24, Authorised, Last updated: 07/07/2023
Levetiracetam Hospira Nervous System Diseases Central … Authorised levetiracetam Overview Levetiracetam Hospira is an epilepsy medicine … reaches the whole brain. Levetiracetam Hospira can also be used … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 19, Authorised, Last updated: 22/06/2023
Levetiracetam Actavis Nervous System Diseases Central … Authorised levetiracetam Overview Levetiracetam Actavis is an epilepsy medicine … reaches the whole brain. Levetiracetam Actavis can also be used … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis Group
levetiracetam, Epilepsy
Date of authorisation: 04/12/2011,, Revision: 18, Authorised, Last updated: 22/06/2023
Levetiracetam Actavis Group Nervous System … Authorised levetiracetam Overview Levetiracetam Actavis Group is an epilepsy … reaches the whole brain. Levetiracetam Actavis Group can also be … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,, Revision: 15, Authorised, Last updated: 26/06/2023
Levetiracetam ratiopharm Nervous System … Authorised levetiracetam Overview This is a summary … assessment report (EPAR) for Levetiracetam ratiopharm. It explains how … -
List item
Human medicine European public assessment report (EPAR): Matever
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 27, Authorised, Last updated: 29/06/2023
Authorised levetiracetam Overview This is a summary … medicine. active substance levetiracetam. It is available as tablets … increased at two-week intervals according to the patient’s response … -
List item
Human medicine European public assessment report (EPAR): Keppra
levetiracetam, Epilepsy
Date of authorisation: 29/09/2000, Revision: 53, Authorised, Last updated: 22/03/2023contains the active substance levetiracetam. It is available as tablets … increased at two-week intervals according to the patient’s response … active substance in Keppra, levetiracetam, is an anti-epileptic medicine … -
List item
Withdrawn application: Tigecycline Accord
tigecycline, date of withdrawal: 12/09/2017, Initial authorisation, Last updated: 10/10/2017Tigecycline Accord: Withdrawn application … Overview On 12 September 2017, Accord Healthcare Limited officially notified … authorisation for Tigecycline Accord, for the treatment of certain … -
List item
Summary of opinion: Degarelix Accord
degarelix acetate, opinion date: 20/07/2023, Positive, Last updated: 21/07/2023Degarelix Accord: Pending EC decision … medicinal product Degarelix Accord, intended for the treatment … action. medicinal product is Accord Healthcare S.L.U. Degarelix Accord will be available as an 80 … -
List item
Direct healthcare professional communication (DHPC): Cabazitaxel Accord 20 mg/mL concentrate for solution for infusion: Risk of medication errors and mix-up with Jevtana (60 mg/1.5 mL) concentrate and solvent for solution for infusion
Active substance: cabazitaxel, DHPC type: Medication error, Last updated: 28/10/2020Cabazitaxel Accord 20 mg/mL concentrate for … Direct healthcare professional communication … communication (DHPC): Cabazitaxel Accord 20 mg/mL concentrate for … -
List item
Withdrawn application: Erlotinib Accord
erlotinib, date of withdrawal: 28/05/2020, Initial authorisation, Last updated: 29/05/2020Erlotinib Accord: Withdrawn application … medicines are manufactured according to the same quality standards … Erlotinib Accord Erlotinib Accord erlotinib … -
List item
Human medicine European public assessment report (EPAR): Lacosamide Accord
lacosamide, Epilepsy
Date of authorisation: 18/09/2017,, Revision: 12, Authorised, Last updated: 16/08/2023
Lacosamide Accord Nervous System Diseases Central … report (EPAR) for Lacosamide Accord. It explains how the Agency … on how to use Lacosamide Accord. For practical information … -
List item
Human medicine European public assessment report (EPAR): Tolvaptan Accord
Tolvaptan, Inappropriate ADH Syndrome, Authorised, Last updated: 14/08/2023
Tolvaptan Accord Pituitary Diseases Hypothalamic … tolvaptan Overview Tolvaptan Accord is a medicine for treating … in the blood. Tolvaptan Accord is a ‘ A generic medicine … -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 11, Authorised, Last updated: 22/09/2023
Lenalidomide Accord Cancer Neoplasms Neoplasms … Lenalidomide Accord is a medicine used for the … multiple myeloma, Lenalidomide Accord is used: in adults who have … -
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Accord
cabazitaxel, Prostatic Neoplasms, Castration-Resistant
Date of authorisation: 28/08/2020,, Revision: 5, Authorised, Last updated: 27/07/2023
Cabazitaxel Accord Prostatic Neoplasms Genital … cabazitaxel Overview Cabazitaxel Accord is a cancer medicine used to … prostate fluid). Cabazitaxel Accord is used when the cancer has … -
List item
Human medicine European public assessment report (EPAR): Deferasirox Accord (updated)
deferasirox, Iron Overload; beta-Thalassemia
Date of authorisation: 09/01/2020,, Revision: 5, Authorised, Last updated: 14/09/2023
Deferasirox Accord Nutritional and Metabolic … deferasirox Overview Deferasirox Accord is a medicine used to treat … from the gut. Deferasirox Accord contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Rivaroxaban Accord (updated)
rivaroxaban, Acute Coronary Syndrome; Coronary Artery Disease; Peripheral Arterial Disease; Venous Thromboembolism; Stroke; Atrial Fibrillation; Pulmonary Embolism
Date of authorisation: 16/11/2020,, Revision: 5, Authorised, Last updated: 28/09/2023
Rivaroxaban Accord Cardiovascular Diseases Vascular … rivaroxaban Overview Rivaroxaban Accord is an anticoagulant medicine … with aspirin. Rivaroxaban Accord contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Accord (updated)
docetaxel, Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Prostatic Neoplasms; Breast Neoplasms
Date of authorisation: 22/05/2012,, Revision: 17, Authorised, Last updated: 14/09/2023
Docetaxel Accord Cancer Neoplasms Breast … docetaxel Overview Docetaxel Accord is a cancer medicine used … breast cancer. Docetaxel Accord can be used on its own after … -
List item
Human medicine European public assessment report (EPAR): Dexmedetomidine Accord
dexmedetomidine, Premedication
Date of authorisation: 13/02/2020,, Revision: 6, Authorised, Last updated: 25/01/2023
Dexmedetomidine Accord Therapeutics Drug Therapy … Overview Dexmedetomidine Accord is a medicine used to sedate … sedation). Dexmedetomidine Accord contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Plerixafor Accord
Plerixafor, Multiple Myeloma; Hematopoietic Stem Cell Transplantation
Date of authorisation: 16/12/2022,
, , Revision: 1, Authorised, Last updated: 07/08/2023
Plerixafor Accord Lymphoproliferative Disorders Lymphatic … plerixafor Overview Plerixafor Accord is a medicine used to mobilise … same patient. Plerixafor Accord is used together with the … -
List item
Human medicine European public assessment report (EPAR): Azacitidine Accord
azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020,, Revision: 6, Authorised, Last updated: 29/03/2023
Azacitidine Accord Cancer Neoplasms Bone … azacitidine Overview Azacitidine Accord is used for the treatment … myeloid cells). Azacitidine Accord is used in patients with … -
List item
Human medicine European public assessment report (EPAR): Teriflunomide Accord
Teriflunomide, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 09/11/2022,, Authorised, Last updated: 14/11/2022
Teriflunomide Accord Multiple Sclerosis Demyelinating … Teriflunomide Accord is a medicine used to treat … themselves. Teriflunomide Accord is used in the type of MS … -
List item
Human medicine European public assessment report (EPAR): Apixaban Accord
Apixaban, Venous Thromboembolism; Stroke; Arthroplasty
Date of authorisation: 23/07/2020,, Revision: 2, Authorised, Last updated: 19/05/2022
Apixaban Accord Thromboembolism Embolism … apixaban Overview Apixaban Accord is a medicine used to prevent … reoccurrence. Additionally, Apixaban Accord is used to prevent stroke …